You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026 › February › 04

Mounjaro

5 months ago

We're raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat ⊕⊕

found 2026 › Feb › 04 (Wed) @ 19:57 UTC

a story from CNBC ⚠️ › Top News

Combined sales for the company's blockbuster GLP-1 drugs Zepbound and Mounjaro exceeded $1 billion, with each showing triple-digit growth.

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar ⊕

found 2026 › Feb › 04 (Wed) @ 12:06 UTC

a story from CNBC ⚠️ › Top News

Eli Lilly's fourth-quarter earnings come as it tries to maintain its advantage over Novo Nordisk in the GLP-1 market.

page 1 of 1